Uncategorized
Anti-complement C5 monotherapy ineffective in reducing geographic atrophy lesion size
MIAMI — An anti-complement C5 therapy had no different effect on geographic atrophy lesion size than sham therapy, according to a presentation at Angiogenesis, Exudation, and Degeneration 2016.“No efficacy was observed,” Parisa Zamiri, MD, PhD, said of the treatment drug LFG316 in her presentation on the drug’s 12-month safety and efficacy results.